Literature DB >> 10399075

Cytomegalovirus evasion of natural killer cell responses.

H E Farrell1, M A Degli-Esposti, N J Davis-Poynter.   

Abstract

Natural killer (NK) cells are an important component of the innate cellular immune system. They are particularly important during the early immune responses following virus infection, prior to the induction of cytotoxic T cells (CTL). Unlike CTL, which recognize specific peptides displayed on the surface of cells by class I MHC, NK cells respond to aberrant expression of cell surface molecules, in particular class I MHC, in a non-specific manner. Thus, cells expressing low levels of surface class I MHC are susceptible to recognition by NK cells, with concomitant triggering of cytolytic and cytokine-mediated responses. Many viruses, including the cytomegaloviruses, downregulate cell surface MHC class I: this is likely to provide protection against CTL-mediated clearance of infected cells, but may also render infected cells sensitive to NK-cell attack. This review focuses upon cytomegalovirus-encoded proteins that are believed to promote evasion of NK-cell-mediated immunity. The class I MHC homologues, encoded by all cytomegaloviruses characterised to date, have been implicated as molecular 'decoys', which may mimic the ability of cellular MHC class I to inhibit NK-cell functions. Results from studies in vitro are not uniform, but in general they support the proposal that the class I homologues engage inhibitory receptors from NK cells and other cell types that normally interact with cellular class I. Consistent with this, in vivo studies of murine cytomegalovirus indicate that the class I homologue is required for efficient evasion of NK-cell-mediated clearance. Recently a second murine cytomegalovirus protein, a C-C chemokine homologue, has been implicated as promoting evasion of NK and T-cell-mediated clearance in vivo.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10399075     DOI: 10.1111/j.1600-065x.1999.tb01293.x

Source DB:  PubMed          Journal:  Immunol Rev        ISSN: 0105-2896            Impact factor:   12.988


  10 in total

Review 1.  Fugetaxis: active movement of leukocytes away from a chemokinetic agent.

Authors:  Fabrizio Vianello; Ivona T Olszak; Mark C Poznansky
Journal:  J Mol Med (Berl)       Date:  2005-09-03       Impact factor: 4.599

2.  Absence of vasoactive intestinal peptide expression in hematopoietic cells enhances Th1 polarization and antiviral immunity in mice.

Authors:  Jian-Ming Li; Lauren Southerland; Mohammad S Hossain; Cynthia R Giver; Ying Wang; Kasia Darlak; Wayne Harris; James Waschek; Edmund K Waller
Journal:  J Immunol       Date:  2011-06-15       Impact factor: 5.422

Review 3.  Viral escape mechanisms--escapology taught by viruses.

Authors:  M Lucas; U Karrer; A Lucas; P Klenerman
Journal:  Int J Exp Pathol       Date:  2001-10       Impact factor: 1.925

4.  Immune evasion by herpes simplex virus type 1, strategies for virus survival.

Authors:  Harvey M Friedman
Journal:  Trans Am Clin Climatol Assoc       Date:  2003

5.  Expansion of protective CD8+ T-cell responses driven by recombinant cytomegaloviruses.

Authors:  Urs Karrer; Markus Wagner; Sophie Sierro; Annette Oxenius; Hartmut Hengel; Tilman Dumrese; Stefan Freigang; Ulrich H Koszinowski; Rodney E Phillips; Paul Klenerman
Journal:  J Virol       Date:  2004-03       Impact factor: 5.103

6.  Identification of a mouse cytomegalovirus gene selectively targeting CD86 expression on antigen-presenting cells.

Authors:  Andrea Loewendorf; Corinna Krüger; Eva Maria Borst; Markus Wagner; Ursula Just; Martin Messerle
Journal:  J Virol       Date:  2004-12       Impact factor: 5.103

7.  Comparison of Real-time PCR to ELISA for the detection of human cytomegalovirus infection in renal transplant patients in the Sudan.

Authors:  Khalid A Enan; Hanna Rennert; Ali M El-Eragi; Abdel Rahim M El Hussein; Isam M Elkhidir
Journal:  Virol J       Date:  2011-05-13       Impact factor: 4.099

8.  Activation mechanisms of natural killer cells during influenza virus infection.

Authors:  Ilwoong Hwang; Jeannine M Scott; Tejaswi Kakarla; David M Duriancik; Seohyun Choi; Chunghwan Cho; Taehyung Lee; Hyojin Park; Anthony R French; Eleni Beli; Elizabeth Gardner; Sungjin Kim
Journal:  PLoS One       Date:  2012-12-31       Impact factor: 3.240

9.  VIPhyb, an antagonist of vasoactive intestinal peptide receptor, enhances cellular antiviral immunity in murine cytomegalovirus infected mice.

Authors:  Jian-Ming Li; Kasia A Darlak; Lauren Southerland; Mohammad S Hossain; David L Jaye; Cassandra D Josephson; Hilary Rosenthal; Edmund K Waller
Journal:  PLoS One       Date:  2013-05-27       Impact factor: 3.240

10.  Human cytomegalovirus glycoprotein UL16 causes intracellular sequestration of NKG2D ligands, protecting against natural killer cell cytotoxicity.

Authors:  Claire Dunn; N Jan Chalupny; Claire L Sutherland; Stephanie Dosch; P V Sivakumar; David C Johnson; David Cosman
Journal:  J Exp Med       Date:  2003-06-02       Impact factor: 14.307

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.